Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
41 Cards in this Set
- Front
- Back
function of GnRH
|
stimulated release of FSH and LH from the pituitary to regulate androgens, estrogens, and progestins
|
|
GnRH replacements
|
GnRH itself, leuprolide, nafarelin, buserelin, desorelin, histrelin, goserelin
|
|
GnRG as a diagnostic tool
|
-distinguish between constitutionally delayed puberty (low LH) and hypogonadotropic hypogonadism
|
|
GnRH as a drug
|
stimulation of gonadal function in hypogonadotropic hypogonadism, delayed puberty or cryptorchidism
-must be given in pulses by an IV pump -not used due to cost and inconvenience of pump |
|
GnRH analogues used for:
|
-suppression of gonadal function--"chemical castration"
-continuous administration block gonadotropin release by downregulating GnRH receptors -also in precocious puberty and prostate/breast cancer |
|
problems associated with using GnRH analogues
|
-initial increase in gonadotropins
-hot flashes in men and women -headache and abdominal discomfort -vaginal dryness and atrophy -osteoporosis in women |
|
GnRH receptor antagonists
|
-now imporved so they don't release histamine
-able to avoid initial gonadotropin release -EX: ganirelix for androgen replacement therapy |
|
Natural Gonadotropins
|
-follicle-stimulatin hormone
-leutinizing hormone -human chorionic gonadotropin |
|
Urofollitropin (Fertinex)
|
FSH, no LH
|
|
menotropin OR human menopausal gonadotropins
|
purified FSH and LH
|
|
Human Chorionic Gonadotropin
|
LH like activity
|
|
follitropin alpha and beta
|
recombinant FSH
|
|
uses of urofollitropin or menotropins
|
-stimulation of follicular growth for ovulation
-urofollitropin used only after clomiphene -used daily then use hCG to induce ovulation -urofollitropin used in polycystic ovary syndrome -both also used to stimulate spermatogenesis |
|
uses of hCG
|
-induce ovulation
-induce masculinization in men -with menotropins to induce spermatogenesis -treat cryptochidism -test Leydig cell function for testosterone production |
|
adverse effects of gonadotropins
|
-ovarian enlargement or hyperstimulation
-ectopic pregnancy -pulmonary and vascular complications |
|
contraidications of gonadotropin use
|
-primary ovarian failure
-ovarian cysts -dysfunctional abnormal bleeding |
|
adverse effects of hCG
|
-angioedema
-gynecomastia -ovarian enlargement -ovarian hyperstimulation syndrome -pelvic pain |
|
contraindications for hCG
|
-dysfunctional abnormal bleeding
-ovarian failure -prostate carcinoma |
|
major androgens
|
testosterone and dihydrotestosterone
|
|
testosterone production
|
-from androsenedione
-by 17 beta hydroxysteroid dehydrogenase -controled by LH |
|
5 alpha reductase
|
-produces dihydrotestosterone from testosterone
-two forms: 5 alpha R1 (liver, non-genital skin, and brain), 5 alpha R2 (liver and urogenital tract) |
|
site of testosterone production
|
-testes in male
-adrenal gland in females and children |
|
testosterone feedback
|
-must be converted to estridiol by aromatase
-estradiol blocks GnRh -inhibin block FSH |
|
androgen administration
|
-transdermal patch: Testoderm and Androgel
-esters at C17: prepionate, cypionate, enanthate groups -17 alpha aklyl derivatves: Danazol, Fluoxymesterone, Stanozolol, Methyltestosterone |
|
androgen pharmacokinetics
|
-11 min half life
-98% bound to albumin or sex hormone binding globulin -conjugated in liver for urine escretion -most in urine from adrenal production |
|
testosterone esters pharmacokinetics
|
-parentteral admin. slows absorption and lengthens duration
-proprionate: 2-3 days -cypionate and enanthate: 1-2 weeks -esterases remove esters and metabolized like testosterone |
|
17 alpha alkyl derivatives pharmacokinetics
|
-derivatives-specific metabolism
-modifications alter absorption and excretion -some excreted unmetabolized |
|
actions of androgens
|
-depends on age and gender
-males: secondary sex characteristics, anabolic growth, epiphyseal closure (by 17 beta estradiol), thinkening of skin, sebum production -female: virilization |
|
androgen therapeutic for hypogonadism
|
-male hypogonadism to allow noraml development
--prepubertal: vigorous and prolonged treatment with long acting testosterone ester --adult: less intense regimen |
|
androgen therapeutic for hypopituiarism
|
-for boys only
-thyroid and cortisol therapy must be started first -GH should be started first in dwarfism -use gradual increase for max anabolic effect |
|
androgen therapeutic for refractory anemias
|
-oxymetholone derivative has high anabolic activity
-stimulates erythropoietin -not used so much becasue of erythropoietin use |
|
androgen therapeutic for wasting states
|
-use testosterone esters, oxymetholone, oxandrolone
-for reversal of protein loss -does well in AIDS-related wasting |
|
minor therapeutic uses of androgens
|
-gynecological disorders
--synthetic androgens with estrogen reduce breast engorgement -prevent postmenopausal endometrial bleeding due to use of estrogen alone -anti-estrogen action of high doses can treat breast cancer |
|
uses of 17 alpha alkyl derivatives
|
treatment of hereditary angioneurotic edema
-danazol is most effective -stanozolol is used prophylactically -promotes production of C1 esterase inhibitor--a non-androgen activity |
|
effects of anabolic androgen abuse
|
-usually use veterinary or designer drugs
-reduction of testosterone and gonadotropins -leades to low sperm count, testicular atrophy, gynecomastia, liver damage/tumor, increased LDL, decreased HDL |
|
adverse effects of androgens
|
-usually due to pharmacodynamics
-most noticeable in women and children -premature epiphyseal closure -hirsutism, deep voice, baldness, clitoral hypertorphy in women -edema from Na and water retention |
|
adveres effects of 17 alpha alkyl derivative
|
-amenorrhea
-endometrial bleeding -jaundice, hepatic tumors, frank liver damage |
|
contraindications of androgen use
|
-prostatic cancer
-heart failure -liver cirrhosis -renal disease -hypoproteinemia |
|
GnRH and analogues as anti-androgens
|
-block androgen syntesis
-gonadorelin, leuprolide, naferelin block LH by continuous administration --receptor down regulation -lowers testosterone production to castration levels |
|
finesteride
|
-5 alpha reductase inhibitor
-blocks testosterone to DHT -reduces prostate volume and prevents hair loss -careful because lowers PSA, indicator of BPH |
|
androgen receptor antagonists
|
-flutamide: treat prostate cancer with GnRH blockade
-bicalutamide: less hepatotoxic than flutamide -cyproterone acetate: orphan drug for severe hirsutism -spironolactone: weak antagonist, hirsutism |